https://www.gosh.nhs.uk/news/update-for-patients-and-families-on-industrial-action/
Update for patients and families on industrial action
11 Nov 2025, 4 p.m.
As you may be aware, some of our Resident Doctors will be taking part in planned industrial action from 7am on Friday 14 November to 7am on Wednesday 19 November.
Please be reassured that providing safe care for our patients and families remains our priority, and we are working hard to continue to best support all our patients and families. Please do still come to the hospital as planned unless you’re advised otherwise by your clinical team.
Who can I speak to if I have further questions?
This is a difficult situation, and we know that this may cause you added worry or concern. Please speak to your clinical team or contact our Patient Advice and Liaison Service (PALS)if you have any further questions:
Email: pals@gosh.nhs.uk
Telephone: 020 7829 7862
Finally, we want to thank our patients, families and carers for their understanding at this difficult time.
Four research projects receive funding to improve understanding and treatment of childhood cancer
Researchers at Great Ormond Street Hospital (GOSH) and UCL Great Ormond Street Institute of Child Health (UCL GOS ICH) have received funding from The Little Princess Trust for four childhood cancer research projects.
New study brings hope for children with rare life-threatening kidney disease
New research funded by Great Ormond Street Hospital Charity (GOSH Charity), LifeArc and Kidney Research UK has taken an important step towards developing a new treatment for serious genetic kidney diseases affecting children.
Building the next generation of paediatric research leaders
From early career clinicians to emerging scientists, the NIHR GOSH Biomedical Research Centre (BRC)’s Academic Training Weekend is shaping the future of paediatric research - bringing together talent, expertise and ambition from across the UK.
Bagri family philanthropy enables UCL study into rare childhood neurological condition treated at GOSH
A generous donation from the Bagri family will underpin a landmark study into gene-editing treatments for Dihydropteridine reductase deficiency (DHPR deficiency), an ultra-rare childhood neurological condition, treated at GOSH